Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.8, 2001-08, pp. : 543-561

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Status of Gene Therapy for Rheumatoid Arthritis

By Reinecke J.

BioDrugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 103-114

Adis International

Access to resources Recommend Favorite

Recent Advances in Anti-Tumour Necrosis Factor (TNF) Therapy in Rheumatoid Arthritis: Focus on the Soluble TNF Receptor p75 Fusion Protein, Etanercept

By Moreland L.W.

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 201-210

Adis International

Access to resources Recommend Favorite

Spotlight on Infliximab in Crohn Disease and Rheumatoid Arthritis

By Siddiqui M. Asif A. Scott Lesley J.

BioDrugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 67-70

Adis International

Access to resources Recommend Favorite

Biological Agents in Rheumatoid Arthritis: Which Ones Could Be Used in Combination?

By Lorenz M. Kalden J.R.

BioDrugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 303-324

Adis International

Access to resources Recommend Favorite

MicroRNAs in Rheumatoid Arthritis: Potential Role in Diagnosis and Therapy

By Filková Mária Jüngel Astrid Gay Renate E. Gay Steffen

BioDrugs, Vol. 26, Iss. 3, 2012-06 ,pp. : 131-141

Adis International

Access to resources Recommend Favorite